High Free Cash Flow Stocks
ILM1.DE is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
MEDIOS AG (ILM1.DE) Stock Price & Overview
FRA:ILM1 • DE000A1MMCC8
Current stock price
13.66 EUR
+0.25 (+1.86%)
Last:
The current stock price of ILM1.DE is 13.66 EUR. Today ILM1.DE is up by 1.86%. In the past month the price decreased by -2.4%. In the past year, price increased by 12.5%.
ILM1.DE Key Statistics
52-Week Range11.12 - 17.44
Current ILM1.DE stock price positioned within its 52-week range.
1-Month Range11.64 - 14.36
Current ILM1.DE stock price positioned within its 1-month range.
- Market Cap
- 348.467M
- P/E
- 22.39
- Fwd P/E
- 10.92
- EPS (TTM)
- 0.61
- Dividend Yield
- N/A
ILM1.DE Stock Performance
Today
+1.86%
1 Week
+2.68%
1 Month
-2.40%
3 Months
-17.53%
Longer-term
6 Months +5.09%
1 Year +12.50%
2 Years -5.30%
3 Years -26.32%
5 Years -61.96%
10 Years N/A
ILM1.DE Stock Chart
ILM1.DE Stock Screens
ILM1.DE currently appears in the following ChartMill screener lists.
Low P/E Stocks
ILM1.DE is currently part of our Low P/E Stocks screen, indicating it cheap while it also meets financial health criteria.
Value Stocks with Strong Balance Sheets
ILM1.DE is currently part of our value stocks with Strong Balance Sheets screen, indicating it cheap while meeting strict financial health and debt criteria.
Strong Buy Rated Stocks
ILM1.DE is part of our Strong Buy Rated Stocks screen, indicating it has a strong buy ratings from analysts and supporting business quality.
ILM1.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ILM1.DE. When comparing the yearly performance of all stocks, ILM1.DE is a bad performer in the overall market: 78.53% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
ILM1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE. ILM1.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ILM1.DE Earnings
Next Earnings DateMay 12, 2026
Last Earnings DateMar 26, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
ILM1.DE Forecast & Estimates
11 analysts have analysed ILM1.DE and the average price target is 23.46 EUR. This implies a price increase of 71.74% is expected in the next year compared to the current price of 13.66.
For the next year, analysts expect an EPS growth of 19.26% and a revenue growth 4.09% for ILM1.DE
Analysts
Analysts87.27
Price Target23.46 (71.74%)
EPS Next Y19.26%
Revenue Next Year4.09%
ILM1.DE Groups
Sector & Classification
ILM1.DE Financial Highlights
Over the last trailing twelve months ILM1.DE reported a non-GAAP Earnings per Share(EPS) of 0.61. The EPS increased by 18.49% compared to the year before.
Income Statements
Revenue(TTM)2.08B
Net Income(TTM)15.37M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.74% | ||
| ROA | 1.7% | ||
| ROE | 2.99% | ||
| Debt/Equity | 0.33 |
Chartmill High Growth Momentum
EPS Q2Q%-330.1%
Sales Q2Q%13.7%
EPS 1Y (TTM)18.49%
Revenue 1Y (TTM)10.39%
ILM1.DE Ownership
Ownership
Inst Owners37.09%
Shares25.51M
Float15.63M
Ins Owners19.7%
Short Float %N/A
Short RatioN/A
ILM1.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Distributors" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AXNA | AMPLIFON SPA | 15.34 | 2.302B | ||
| AMP | AMPLIFON SPA | 15.11 | 2.266B | ||
| FAGR | FAGRON | 15.93 | 1.793B | ||
| UPR | UNIPHAR PLC | 16.28 | 1.085B | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 12.53 | 190.883M | ||
| PRE | PREDICT SPA | N/A | 4.345M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About ILM1.DE
Company Profile
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Company Info
IPO: 1999-01-01
MEDIOS AG
Heidestrasse 9
Berlin BERLIN DE
Employees: 999
Phone: 4930232566800
MEDIOS AG / ILM1.DE FAQ
What does ILM1 do?
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
What is the current price of ILM1 stock?
The current stock price of ILM1.DE is 13.66 EUR. The price increased by 1.86% in the last trading session.
What is the dividend status of MEDIOS AG?
ILM1.DE does not pay a dividend.
What is the ChartMill rating of MEDIOS AG stock?
ILM1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the employee count for ILM1 stock?
MEDIOS AG (ILM1.DE) currently has 999 employees.
What is the ownership structure of MEDIOS AG (ILM1.DE)?
You can find the ownership structure of MEDIOS AG (ILM1.DE) on the Ownership tab.